Takeda Pharmaceutical Co Ltd 20-F for FY2025
Takeda Pharmaceutical Co Ltd (TAK)
20-F
2025-06-25
For: 2025-03-31
View Original
Added on
April 07, 2026
About this 20-F
Takeda Pharmaceutical Co Ltd filed this 20-F on June 25, 2025, covering the fiscal year ended March 31, 2025 (FY2025).
Headline figures
Fiscal year ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 4.58T JPY
- up 7.5% from 4.26T JPY a year earlier
- Net income
- 107.93B JPY
- down 25.1% from net income of 144.07B JPY a year earlier
- Diluted EPS
- 67.23 JPY
- down 26.3% from 91.16 JPY a year earlier